Published in Infect Immun on May 19, 2008
Colonization by Pneumocystis jirovecii and its role in disease. Clin Microbiol Rev (2012) 1.68
Cigarette smoke exposure impairs pulmonary bacterial clearance and alveolar macrophage complement-mediated phagocytosis of Streptococcus pneumoniae. Infect Immun (2009) 1.22
Airway obstruction is increased in pneumocystis-colonized human immunodeficiency virus-infected outpatients. J Clin Microbiol (2009) 1.20
HIV and chronic obstructive pulmonary disease: is it worse and why? Proc Am Thorac Soc (2011) 1.18
Pathogenesis of HIV and the lung. Curr HIV/AIDS Rep (2013) 1.06
Relationship of Pneumocystis jiroveci humoral immunity to prevention of colonization and chronic obstructive pulmonary disease in a primate model of HIV infection. Infect Immun (2010) 0.99
Activated alveolar epithelial cells initiate fibrosis through secretion of mesenchymal proteins. Am J Pathol (2013) 0.97
The microbiome and the lung. Ann Am Thorac Soc (2014) 0.97
Combined quantification of pulmonary Pneumocystis jirovecii DNA and serum (1->3)-β-D-glucan for differential diagnosis of pneumocystis pneumonia and Pneumocystis colonization. J Clin Microbiol (2013) 0.93
Topographic diversity of the respiratory tract mycobiome and alteration in HIV and lung disease. Am J Respir Crit Care Med (2015) 0.93
Distribution of Pneumocystis jirovecii in lungs from colonized COPD patients. Diagn Microbiol Infect Dis (2011) 0.91
Human immunodeficiency virus-associated obstructive lung diseases. Clin Chest Med (2013) 0.89
Factors associated with abnormal spirometry among HIV-infected individuals. AIDS (2015) 0.87
Pneumocystis jirovecii colonization in chronic pulmonary disease. Parasite (2011) 0.86
Lung Malignancies in HIV Infection. Semin Respir Crit Care Med (2016) 0.85
Pneumocystis jirovecii colonization is associated with enhanced Th1 inflammatory gene expression in lungs of humans with chronic obstructive pulmonary disease. Microbiol Immunol (2014) 0.85
Critical roles of inflammation and apoptosis in improved survival in a model of hyperoxia-induced acute lung injury in Pneumocystis murina-infected mice. Infect Immun (2009) 0.85
Tobacco use and cessation in HIV-infected individuals. Clin Chest Med (2013) 0.84
Experimental Pneumocystis lung infection promotes M2a alveolar macrophage-derived MMP12 production. Am J Physiol Lung Cell Mol Physiol (2012) 0.79
Pneumocystis murina colonization in immunocompetent surfactant protein A deficient mice following environmental exposure. Respir Res (2009) 0.79
Trimethoprim-sulfamethoxazole treatment does not reverse obstructive pulmonary changes in pneumocystis-colonized nonhuman primates with SHIV infection. J Acquir Immune Defic Syndr (2014) 0.76
Lung cancer in persons with HIV. Curr Opin HIV AIDS (2017) 0.75
The respiratory microbiome of HIV-infected individuals. Expert Rev Anti Infect Ther (2016) 0.75
Infections in the immunosuppressed host. Ann Am Thorac Soc (2014) 0.75
Pneumocystis jirovecii detection in asymptomatic patients: what does its natural history tell us? F1000Res (2017) 0.75
Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice. Science (1997) 8.19
Requirement for CD4+ cells in resistance to Pneumocystis carinii pneumonia in mice. J Exp Med (1990) 3.20
A new model of Pneumocystis carinii infection in mice selectively depleted of helper T lymphocytes. J Clin Invest (1990) 3.03
Increased COPD among HIV-positive compared to HIV-negative veterans. Chest (2006) 2.93
Increased susceptibility to pulmonary emphysema among HIV-seropositive smokers. Ann Intern Med (2000) 2.77
CD8+ve cells in the lungs of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (1999) 2.52
Expression of the reverse tetracycline-transactivator gene causes emphysema-like changes in mice. Am J Respir Cell Mol Biol (2006) 2.46
Association of chronic obstructive pulmonary disease severity and Pneumocystis colonization. Am J Respir Crit Care Med (2004) 2.05
CD8+ T Cells are required for inflammation and destruction in cigarette smoke-induced emphysema in mice. J Immunol (2007) 1.92
Both immunity and hyperresponsiveness to Pneumocystis carinii result from transfer of CD4+ but not CD8+ T cells into severe combined immunodeficiency mice. J Clin Invest (1992) 1.81
CD4+ T cell-independent vaccination against Pneumocystis carinii in mice. J Clin Invest (2001) 1.76
The association between cigarette smoking and selected HIV-related medical conditions. AIDS (1996) 1.72
Immune-mediated inflammation directly impairs pulmonary function, contributing to the pathogenesis of Pneumocystis carinii pneumonia. J Clin Invest (1999) 1.69
Lymphocyte population and apoptosis in the lungs of smokers and their relation to emphysema. Eur Respir J (2001) 1.68
Pneumocystis carinii pneumonia: a cluster of eleven cases. Ann Intern Med (1975) 1.66
Transmission of Pneumocystis carinii disease from immunocompetent contacts of infected hosts to susceptible hosts. Eur J Clin Microbiol Infect Dis (2000) 1.55
Clusters of Pneumocystis carinii pneumonia: analysis of person-to-person transmission by genotyping. QJM (1998) 1.54
Environmentally induced changes in immunological function: acute and chronic effects of inhalation of tobacco smoke and other atmospheric contaminants in man and experimental animals. Bacteriol Rev (1977) 1.51
Airway inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (1999) 1.48
Increased risk of Pneumocystis carinii and community-acquired pneumonia with tobacco use in HIV disease. Int J Infect Dis (2005) 1.46
Cigarette smoke decreases pulmonary dendritic cells and impacts antiviral immune responsiveness. Am J Respir Cell Mol Biol (2003) 1.46
Impact of tobacco use on the development of opportunistic respiratory infections in HIV seropositive patients on antiretroviral therapy. Addict Biol (2003) 1.44
Molecular characterization of KEX1, a kexin-like protease in mouse Pneumocystis carinii. Gene (2000) 1.38
Animal models for chronic obstructive pulmonary disease: age of klotho and marlboro mice. Am J Respir Cell Mol Biol (2000) 1.28
Role of CD8+ lymphocytes in host defense against Pneumocystis carinii in mice. J Lab Clin Med (1996) 1.28
Pulmonary complications of HIV infection. Report of the Fourth NHLBI Workshop. Am J Respir Crit Care Med (2001) 1.23
Emphysematous lung destruction by cigarette smoke. The effects of latent adenoviral infection on the lung inflammatory response. Am J Respir Cell Mol Biol (2002) 1.20
Susceptibility to Pneumocystis carinii in mice is dependent on simultaneous deletion of IFN-gamma and type 1 and 2 TNF receptor genes. J Immunol (1998) 1.19
Exposure of immunocompetent adult mice to Pneumocystis carinii f. sp. muris by cohousing: growth of P. carinii f. sp. muris and host immune response. Infect Immun (2003) 1.18
Haemophilus influenzae in lung explants of patients with end-stage pulmonary disease. Am J Respir Crit Care Med (1998) 1.18
An Official ATS Workshop Summary: Recent advances and future directions in pneumocystis pneumonia (PCP). Proc Am Thorac Soc (2006) 1.16
Systemic inflammation in patients with chronic obstructive pulmonary disease who are colonized with Pneumocystis jiroveci. Clin Infect Dis (2007) 1.13
Nitric oxide and host defense against Pneumocystis carinii infection in a mouse model. J Infect Dis (1996) 1.10
Pulmonary inflammation disrupts surfactant function during Pneumocystis carinii pneumonia. Infect Immun (2001) 1.08
The pathophysiology of pulmonary diffusion impairment in human immunodeficiency virus infection. Am J Respir Crit Care Med (1999) 1.05
Pneumocystis colonization, airway inflammation, and pulmonary function decline in acquired immunodeficiency syndrome. Immunol Res (2006) 1.05
Pneumocystis carinii pneumonia in patients without HIV infection. Am J Med Sci (2001) 1.02
Predictors for failure of Pneumocystis carinii pneumonia prophylaxis. Multicenter AIDS Cohort Study. JAMA (1995) 1.00
Emphysema in nonsmokers: alpha 1-antitrypsin deficiency and other causes. Cleve Clin J Med (2002) 0.99
An outbreak of Pneumocystis carinii pneumonia at a pediatric hospital. Pediatrics (1978) 0.99
Pneumocystis jiroveci isolates with dihydropteroate synthase mutations in patients with chronic bronchitis. Eur J Clin Microbiol Infect Dis (2004) 0.98
Gene expression profiling in lung tissues from mice exposed to cigarette smoke, lipopolysaccharide, or smoke plus lipopolysaccharide by inhalation. Inhal Toxicol (2006) 0.95
CD8+ T cells contribute to macrophage accumulation and airspace enlargement following repeated irritant exposure. Exp Mol Pathol (2007) 0.94
Serum IgG and IgA antibodies to Chlamydia pneumoniae and severity of emphysema. Respirology (2005) 0.94
Multiple inflammatory hits and the pathogenesis of severe airway disease. Eur Respir J (2006) 0.93
Dietary beta-carotene protects lung and liver parenchyma of rats treated with monocrotaline. Toxicology (1999) 0.91
Chronic Chlamydia pneumoniae infection is a risk factor for the development of COPD. Respir Med (2005) 0.89
Expression and complexity of the PRT1 multigene family of Pneumocystis carinii. Microbiology (2004) 0.89
Current concepts in mechanisms of emphysema. Toxicol Pathol (2007) 0.88
Effect of nicotine on lung S-adenosylmethionine and development of Pneumocystis pneumonia. J Biol Chem (2005) 0.87
Mainstream and sidestream cigarette smoke condensates suppress macrophage responsiveness to interferon gamma. Hum Exp Toxicol (1999) 0.85
Detection of rat Pneumocystis carinii proteinases and elastase and antipneumocystis activity of proteinase inhibitors in vitro. Parasite (1999) 0.80
Pneumocystis pneumonia increases the susceptibility of mice to sublethal hyperoxia. Infect Immun (2003) 0.80
Application of immunoblotting to detect soluble Pneumocystis carinii antigen(s) in bronchoalveolar lavage of patients with Pneumocystis pneumonia and AIDS. J Clin Pathol (1990) 0.77
Azithromycin for prevention of exacerbations of COPD. N Engl J Med (2011) 8.66
Pulmonary arterial enlargement and acute exacerbations of COPD. N Engl J Med (2012) 5.54
Analysis of the lung microbiome in the "healthy" smoker and in COPD. PLoS One (2011) 4.65
A vital role for interleukin-21 in the control of a chronic viral infection. Science (2009) 4.55
Chronic obstructive pulmonary disease phenotypes: the future of COPD. Am J Respir Crit Care Med (2010) 4.19
Predictors of mortality in patients with emphysema and severe airflow obstruction. Am J Respir Crit Care Med (2006) 3.71
Comparison of the respiratory microbiome in healthy nonsmokers and smokers. Am J Respir Crit Care Med (2013) 3.65
Simvastatin for the prevention of exacerbations in moderate-to-severe COPD. N Engl J Med (2014) 3.51
Chronic obstructive pulmonary disease exacerbations in the COPDGene study: associated radiologic phenotypes. Radiology (2011) 3.30
Gender and chronic obstructive pulmonary disease: why it matters. Am J Respir Crit Care Med (2007) 2.80
Sex differences in severe pulmonary emphysema. Am J Respir Crit Care Med (2007) 2.77
Expression of the reverse tetracycline-transactivator gene causes emphysema-like changes in mice. Am J Respir Cell Mol Biol (2006) 2.46
Relationship between quantitative CT metrics and health status and BODE in chronic obstructive pulmonary disease. Thorax (2012) 2.15
A combined pulmonary-radiology workshop for visual evaluation of COPD: study design, chest CT findings and concordance with quantitative evaluation. COPD (2012) 2.07
Leaky termination at premature stop codons antagonizes nonsense-mediated mRNA decay in S. cerevisiae. RNA (2004) 2.02
Significance of the microbiome in obstructive lung disease. Thorax (2012) 1.97
Lung dendritic cell expression of maturation molecules increases with worsening chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2009) 1.90
Sex, depression, and risk of hospitalization and mortality in chronic obstructive pulmonary disease. Arch Intern Med (2007) 1.77
Widespread colonization of the lung by Tropheryma whipplei in HIV infection. Am J Respir Crit Care Med (2013) 1.66
Analysis of the upper respiratory tract microbiotas as the source of the lung and gastric microbiotas in healthy individuals. MBio (2015) 1.56
Increased cytokine response of rhinovirus-infected airway epithelial cells in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2010) 1.51
Accumulation of CD11b+ lung dendritic cells in response to fungal infection results from the CCR2-mediated recruitment and differentiation of Ly-6Chigh monocytes. J Immunol (2009) 1.48
Clinical significance of radiologic characterizations in COPD. COPD (2009) 1.41
CCR2 mediates conventional dendritic cell recruitment and the formation of bronchovascular mononuclear cell infiltrates in the lungs of mice infected with Cryptococcus neoformans. J Immunol (2008) 1.39
Cryptococcal urease promotes the accumulation of immature dendritic cells and a non-protective T2 immune response within the lung. Am J Pathol (2009) 1.38
Plasminogen activator inhibitor-1 impairs alveolar epithelial repair by binding to vitronectin. Am J Respir Cell Mol Biol (2004) 1.34
TLR3 increases disease morbidity and mortality from vaccinia infection. J Immunol (2008) 1.26
CC chemokine receptor 5 and CXC chemokine receptor 6 expression by lung CD8+ cells correlates with chronic obstructive pulmonary disease severity. Am J Pathol (2007) 1.26
Application of a neutral community model to assess structuring of the human lung microbiome. MBio (2015) 1.25
Distinct eRF3 requirements suggest alternate eRF1 conformations mediate peptide release during eukaryotic translation termination. Mol Cell (2008) 1.25
Role of macrolide therapy in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2008) 1.24
Cigarette smoke exposure impairs pulmonary bacterial clearance and alveolar macrophage complement-mediated phagocytosis of Streptococcus pneumoniae. Infect Immun (2009) 1.22
CCR2 and CCR6, but not endothelial selectins, mediate the accumulation of immature dendritic cells within the lungs of mice in response to particulate antigen. J Immunol (2005) 1.18
Cytotoxic potential of lung CD8(+) T cells increases with chronic obstructive pulmonary disease severity and with in vitro stimulation by IL-18 or IL-15. J Immunol (2010) 1.18
Elastase- and LPS-exposed mice display altered responses to rhinovirus infection. Am J Physiol Lung Cell Mol Physiol (2009) 1.18
An Official ATS Workshop Summary: Recent advances and future directions in pneumocystis pneumonia (PCP). Proc Am Thorac Soc (2006) 1.16
Chemokine receptor 2-mediated accumulation of fungicidal exudate macrophages in mice that clear cryptococcal lung infection. Am J Pathol (2010) 1.14
Th2 but not Th1 immune bias results in altered lung functions in a murine model of pulmonary Cryptococcus neoformans infection. Infect Immun (2009) 1.12
The scavenger receptor SR-A I/II (CD204) signals via the receptor tyrosine kinase Mertk during apoptotic cell uptake by murine macrophages. J Leukoc Biol (2008) 1.10
Synthetic aminoglycosides efficiently suppress cystic fibrosis transmembrane conductance regulator nonsense mutations and are enhanced by ivacaftor. Am J Respir Cell Mol Biol (2014) 1.10
Delayed clearance of pneumocystis carinii infection, increased inflammation, and altered nitric oxide metabolism in lungs of surfactant protein-D knockout mice. J Infect Dis (2004) 1.09
Enhanced lung injury and delayed clearance of Pneumocystis carinii in surfactant protein A-deficient mice: attenuation of cytokine responses and reactive oxygen-nitrogen species. Infect Immun (2004) 1.09
The class A scavenger receptor, macrophage receptor with collagenous structure, is the major phagocytic receptor for Clostridium sordellii expressed by human decidual macrophages. J Immunol (2010) 1.08
The receptor tyrosine kinase MerTK activates phospholipase C gamma2 during recognition of apoptotic thymocytes by murine macrophages. J Leukoc Biol (2004) 1.08
Anxiety is associated with diminished exercise performance and quality of life in severe emphysema: a cross-sectional study. Respir Res (2010) 1.07
Epidemiology, genetics, and subtyping of preserved ratio impaired spirometry (PRISm) in COPDGene. Respir Res (2014) 1.06
Longitudinal change in the BODE index predicts mortality in severe emphysema. Am J Respir Crit Care Med (2008) 1.05
The predictive role of plasma TGF-beta1 during radiation therapy for radiation-induced lung toxicity deserves further study in patients with non-small cell lung cancer. Lung Cancer (2007) 1.03
The impact of panic disorder on interoception and dyspnea reports in chronic obstructive pulmonary disease. Biol Psychol (2010) 1.03
Quercetin prevents progression of disease in elastase/LPS-exposed mice by negatively regulating MMP expression. Respir Res (2010) 1.02
Specific engagement of TLR4 or TLR3 does not lead to IFN-beta-mediated innate signal amplification and STAT1 phosphorylation in resident murine alveolar macrophages. J Immunol (2004) 1.02
Murine alveolar macrophages limit replication of vaccinia virus. Virology (2007) 1.02
Syk activation is a leukotriene B4-regulated event involved in macrophage phagocytosis of IgG-coated targets but not apoptotic cells. Blood (2003) 1.02
Resident murine alveolar and peritoneal macrophages differ in adhesion of apoptotic thymocytes. Am J Respir Cell Mol Biol (2003) 1.02
Protective effect of Toll-like receptor 4 in pulmonary vaccinia infection. PLoS Pathog (2008) 1.02
Immune reconstitution during Pneumocystis lung infection: disruption of surfactant component expression and function by S-nitrosylation. J Immunol (2009) 1.01
Efferocytosis and lung disease. Chest (2013) 1.00
Neonatal rhinovirus infection induces mucous metaplasia and airways hyperresponsiveness. J Immunol (2012) 1.00
Monocytes recruited to the lungs of mice during immune inflammation ingest apoptotic cells poorly. Am J Respir Cell Mol Biol (2004) 0.98
The microbiome and the lung. Ann Am Thorac Soc (2014) 0.97
Lung CD8+ T cells in COPD have increased expression of bacterial TLRs. Respir Res (2013) 0.97
Recognition and phagocytosis of apoptotic T cells by resident murine tissue macrophages require multiple signal transduction events. J Leukoc Biol (2002) 0.95
C/T polymorphism of the intercellular adhesion molecule-1 gene (exon 6, codon 469). A risk factor for coronary heart disease and myocardial infarction. Int J Cardiol (2002) 0.95
Molecular mechanisms of congenital heart disease. Cardiovasc Pathol (2009) 0.93
Comparison of serum, EDTA plasma and P100 plasma for luminex-based biomarker multiplex assays in patients with chronic obstructive pulmonary disease in the SPIROMICS study. J Transl Med (2014) 0.93
IL-21 is an antitolerogenic cytokine of the late-phase alloimmune response. Diabetes (2011) 0.92
Scavenger receptor A modulates the immune response to pulmonary Cryptococcus neoformans infection. J Immunol (2013) 0.92
Expression and functional implications of CCR2 expression on murine alveolar epithelial cells. Am J Physiol Lung Cell Mol Physiol (2004) 0.91
Elastase/LPS-exposed mice exhibit impaired innate immune responses to bacterial challenge: role of scavenger receptor A. Am J Pathol (2011) 0.90
Disparate mechanisms of sICAM-1 production in the peripheral lung: contrast between alveolar epithelial cells and pulmonary microvascular endothelial cells. Am J Physiol Lung Cell Mol Physiol (2008) 0.90
Activation of protein kinase C beta II by the stereo-specific phosphatidylserine receptor is required for phagocytosis of apoptotic thymocytes by resident murine tissue macrophages. J Biol Chem (2002) 0.90
Semiquantification and classification of local pulmonary function by V/Q single photon emission computed tomography in patients with non-small cell lung cancer: potential indication for radiotherapy planning. J Thorac Oncol (2011) 0.90
Brief report: incidence, etiology, risk factors, and outcome of hospital-acquired fever: a systematic, evidence-based review. J Gen Intern Med (2006) 0.90
Antimicrobial activity against Shigella sonnei and probiotic properties of wild lactobacilli from fermented food. Microbiol Res (2011) 0.89
An official ATS workshop report: Emerging issues and current controversies in HIV-associated pulmonary diseases. Proc Am Thorac Soc (2011) 0.89
Conserved nontypeable Haemophilus influenzae-derived TLR2-binding lipopeptides synergize with IFN-beta to increase cytokine production by resident murine and human alveolar macrophages. J Immunol (2006) 0.88
Procalcitonin-guided antibiotic therapy in COPD exacerbations: closer but not quite there. Chest (2007) 0.88
Effects of copper on the post acidification of fermented milk by St. thermophilus. J Food Sci (2011) 0.88
Smoking decreases the response of human lung macrophages to double-stranded RNA by reducing TLR3 expression. Respir Res (2013) 0.87
Membrane-targeted synergistic activity of docosahexaenoic acid and lysozyme against Pseudomonas aeruginosa. Biochem J (2009) 0.86
Long-term comparative immunogenicity of protein conjugate and free polysaccharide pneumococcal vaccines in chronic obstructive pulmonary disease. Clin Infect Dis (2012) 0.86
P38 mitogen-activated protein kinase inhibition attenuates pulmonary inflammatory response in a rat cardiopulmonary bypass model. Eur J Cardiothorac Surg (2006) 0.85
Critical roles of inflammation and apoptosis in improved survival in a model of hyperoxia-induced acute lung injury in Pneumocystis murina-infected mice. Infect Immun (2009) 0.85
Gender differences in symptoms and care delivery for chronic obstructive pulmonary disease. J Womens Health (Larchmt) (2012) 0.85
Preparation of chitosan-copper complexes and their antitumor activity. Bioorg Med Chem Lett (2006) 0.84
Glucocorticoids relieve collectin-driven suppression of apoptotic cell uptake in murine alveolar macrophages through downregulation of SIRPα. J Immunol (2012) 0.84
Impact of self-reported gastroesophageal reflux disease in subjects from COPDGene cohort. Respir Res (2014) 0.84
T cell costimulatory molecule function determines susceptibility to infection with Pneumocystis carinii in mice. J Immunol (2003) 0.83
Purification and characterization of nattokinase from Bacillus subtilis natto B-12. J Agric Food Chem (2009) 0.83
Randomized trial of zileuton for treatment of COPD exacerbations requiring hospitalization. COPD (2011) 0.83
Combined exposure to cigarette smoke and nontypeable Haemophilus influenzae drives development of a COPD phenotype in mice. Respir Res (2014) 0.83